We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.29B
1-Year Est. Return 4.86%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
-4.86%
3 Year Est. Return
+64.44%
5 Year Est. Return
+96.88%
10 Year Est. Return
+353.21%
AUM
$2.94B
AUM Growth
+$171M
Cap. Flow
-$9.19M
Cap. Flow %
-0.31%
Top 10 Hldgs %
68.26%
Holding
686
New
394
Increased
226
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$1.34M
2
VZ icon
Verizon
VZ
+$1.06M
3
MMP
Magellan Midstream Partners, L.P.
MMP
+$757K
4
SCCO icon
Southern Copper
SCCO
+$748K
5
EPD icon
Enterprise Products Partners
EPD
+$628K

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$22.6M
2
UNP icon
Union Pacific
UNP
+$816K
3
TGT icon
Target
TGT
+$739K
4
DOC icon
Healthpeak Properties
DOC
+$404K
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$137K

Sector Composition

Rank Sector Weight
1 Healthcare 51.92%
2 Energy 8.79%
3 Technology 8.39%
4 Utilities 7.86%
5 Industrials 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CEG icon
576
Constellation Energy
CEG
$92B
$1K ﹤0.01%
+10
New +$829
CFG icon
577
Citizens Financial Group
CFG
$28.2B
$1K ﹤0.01%
+50
New +$1.38K
CHKP icon
578
Check Point Software Technologies
CHKP
$14.1B
$1K ﹤0.01%
+6
New +$755
CMA
579
DELISTED
Comerica
CMA
$1K ﹤0.01%
+35
New +$1.41K
CMI icon
580
Cummins
CMI
$72.6B
$1K ﹤0.01%
+5
New +$1.13K
COTY icon
581
Coty
COTY
$2.32B
$1K ﹤0.01%
+65
New +$767
CPB icon
582
Campbell Soup
CPB
$6.38B
$1K ﹤0.01%
+15
New +$774
CTMX icon
583
CytomX Therapeutics
CTMX
$604M
$1K ﹤0.01%
712
– –
DGX icon
584
Quest Diagnostics
DGX
$27.3B
$1K ﹤0.01%
+5
New +$689
DH icon
585
Definitive Healthcare
DH
$103M
$1K ﹤0.01%
+134
New +$1.38K
DTE icon
586
DTE Energy
DTE
$27.2B
$1K ﹤0.01%
+10
New +$1.11K
EA
587
DELISTED
Electronic Arts
EA
$1K ﹤0.01%
+10
New +$1.27K
EBS icon
588
Emergent Biosolutions
EBS
$346M
$1K ﹤0.01%
+127
New +$1.18K
EIX icon
589
Edison International
EIX
$21.1B
$1K ﹤0.01%
+15
New +$1.05K
ESS icon
590
Essex Property Trust
ESS
$17.4B
$1K ﹤0.01%
+5
New +$1.09K
EXR icon
591
Extra Space Storage
EXR
$28.8B
$1K ﹤0.01%
+5
New +$752
FBIN icon
592
Fortune Brands Innovations
FBIN
$4.72B
$1K ﹤0.01%
+15
New +$954
FLR icon
593
Fluor
FLR
$7.09B
$1K ﹤0.01%
45
– –
FSLR icon
594
First Solar
FSLR
$20.5B
$1K ﹤0.01%
+5
New +$990
GNRC icon
595
Generac Holdings
GNRC
$10.3B
$1K ﹤0.01%
+10
New +$1.14K
GPN icon
596
Global Payments
GPN
$22.9B
$1K ﹤0.01%
+10
New +$1.03K
GRFS
597
Grifois
GRFS
$5.04B
$1K ﹤0.01%
+71
New +$586
GRMN
598
Garmin
GRMN
$53.4B
$1K ﹤0.01%
+10
New +$1.02K
HAL icon
599
Halliburton
HAL
$28.8B
$1K ﹤0.01%
+25
New +$790
HBAN icon
600
Huntington Bancshares
HBAN
$32B
$1K ﹤0.01%
+135
New +$1.44K
22 23
24
25 26

Similar funds

VVP
Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OCM
Oribel Capital Management New York $3.29B AUM 83.82% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.3B AUM 0.25% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $3.3B AUM 16.21% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Bollard Group's Q2 2023 Portfolio in Review

As of Q2 2023, Bollard Group held 686 positions worth $2.94B, up 6.2% from $2.77B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Bollard Group's Q2 2023 filing shows 394 new, 226 increased, 9 reduced and 3 closed positions. Its largest new stake was Charles Schwab: 25,625 shares worth $1.45M. The largest sale was Boston Scientific, an estimated $22.6M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 51% a quarter earlier, followed by Energy and Technology.

  • Bollard Group's largest Q2 2023 buy was Charles Schwab: 25,625 shares worth $1.45M.
  • Bollard Group added most to Verizon in Q2 2023, an estimated $1.06M increase.
  • Bollard Group's biggest Q2 2023 reduction was Boston Scientific, cutting an estimated $22.6M.
  • Bollard Group fully exited Cenovus Energy in Q2 2023, selling an estimated $17.
  • Bollard Group's ten largest holdings make up 68% of its $2.94B portfolio in Q2 2023.
  • Bollard Group opened 394 new positions and closed 3 in Q2 2023.
  • Bollard Group's portfolio value rose 6.2% quarter-over-quarter to $2.94B.

Based on Bollard Group's 13F filing for Q2 2023, filed 14 Aug 2023.